ClinicalTrials.gg

Jazz Pharmaceuticals clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 223 studies whose lead sponsor is Jazz Pharmaceuticals or one of 6 companies grouped under it. 18 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 7 registry names, not the registry’s. See them and correct one ↓

Compare Jazz Pharmaceuticals with Hoffmann-La Roche and CSPC Pharmaceutical Group →

Pipeline: 8 programs

Each counted once: 8 with a study Jazz Pharmaceuticals leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Jazz Pharmaceuticals’ own registered studies; Jazz Pharmaceuticals’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

One of Jazz Pharmaceuticals’ programs has a dated deal behind it: 1 brought in. Each from the companies’ own releases and filings, linked; the registry does not record them.

Brought in 1

What it is testing

The drugs Jazz Pharmaceuticals’ studies test, most open studies first — 41 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 41; every drug is on its own page, and each page lists its sponsors.

Coming up

8 of Jazz Pharmaceuticals’ studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. J’27
  4. 2F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. 2N

Add all 8 to your calendar (.ics) → With an account.

All 223 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now188%Recruiting 16 · Not yet recruiting 2
  • Under way, not recruiting63%
  • Completed14465%
  • Stopped early4520%Terminated 31 · Withdrawn 14
  • Status unknown or other104%Approved for marketing 4 · No longer available 4 · Status unknown 2

Phase

  • Phase 379
  • Phase 275
  • Phase 144
  • Phase 410
  • Early Phase 11

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 1714
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 1026

By the year each study started; 32 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Jazz Pharmaceuticals.

  • Jazz Pharmaceuticals
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    173 studies
  • Chimerix
    Acquired — became part of Jazz Pharmaceuticals, Apr 21, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    33 studies →
  • GW Pharmaceuticals Ltd
    Acquired — became part of Jazz Pharmaceuticals, May 5, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • GW Research Ltd
    Acquired — became part of Jazz Pharmaceuticals, May 5, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Cavion, Inc.
    Acquired — became part of Jazz Pharmaceuticals, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Orphan Medical
    Acquired — became part of Jazz Pharmaceuticals, Jun 24, 2005 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Azur Pharma, Inc
    Acquired — became part of Jazz Pharmaceuticals, Jan 18, 2012 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Jazz Pharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 223. Browse all 223 →